tiprankstipranks
Trending News
More News >
Oncolytics Biotech (ONCY)
NASDAQ:ONCY

Compare Oncolytics Biotech (ONCY) vs. Competitors

Compare
1,479 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Oncolytics Biotech
$0.90
$96.85M
-3.20
25.52%
5 Buy
1 Hold
0 Sell
Strong Buy
Atossa Therapeutics
$5.29
$45.55M
-1.50
-58.35%
4 Buy
0 Hold
0 Sell
Strong Buy
Oramed Pharm
$2.91
$136.12M
3.41
56.16%
Atara Biotherapeutics
$15.79
$35.04M
2.22
-47.74%
1 Buy
1 Hold
0 Sell
Moderate Buy
Zentalis Pharmaceuticals
$1.41
$184.24M
-1.22
56.44%
4 Buy
2 Hold
0 Sell
Moderate Buy
Prelude Therapeutics
$2.45
$130.22M
-1.43
107.21%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ONCY
Oncolytics Biotech
0.90
0.11
13.35%
ATOS
Atossa Therapeutics
5.29
-6.78
-56.19%
ORMP
Oramed Pharm
3.42
1.36
66.02%
ATRA
Atara Biotherapeutics
4.86
-5.65
-53.76%
ZNTL
Zentalis Pharmaceuticals
2.55
0.39
18.06%
PRLD
Prelude Therapeutics
2.30
1.19
107.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts